Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE‐TAVI AF Trial
Authors
Nicolas M. Van Mieghem (ORCID: https://orcid.org/0000-0002-2732-1205)
Christian Hengstenberg (ORCID: https://orcid.org/0000-0002-8284-2994)
Martin Unverdorben (ORCID: https://orcid.org/0000-0002-3601-8187)
Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE‐TAVI AF Trial
Nicolas M. Van Mieghem, Christian Hengstenberg, Martin Unverdorben, Helge Möllmann et al.
Citations
1 citations
Journal
Journal of the American Heart Association
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
1.39
article
Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE‐TAVI AF Trial
Nicolas M. Van Mieghem, Christian Hengstenberg, Martin Unverdorben, Helge Möllmann, Cathy Chen, Masanori Yamamoto, Rainer Hambrecht, George Dangas, Fayaz A. Shawl, Anil Duggal, James Jin, Johny Nicolas, Shigeru Saito
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of the American Heart AssociationVol. 14(10)
Institutions
Daiichi Sankyo (Germany) (DE), National and Kapodistrian University of Athens (GR), The Mount (GB), Vienna General Hospital (AT), Mount Sinai Hospital (US), Toyohashi Heart Center (JP), Daiichi-Sankyo (South Korea) (KR), St.-Johannes-Hospital Dortmund (DE), Klinikum Links der Weser (DE), Shonan Kamakura General Hospital (JP), Erasmus University Rotterdam (NL)